X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs PFIZER - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA PFIZER FULFORD INDIA/
PFIZER
 
P/E (TTM) x 398.8 33.5 1,190.1% View Chart
P/BV x 6.2 4.7 131.2% View Chart
Dividend Yield % 0.1 0.7 11.8%  

Financials

 FULFORD INDIA   PFIZER
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
PFIZER
Mar-18
FULFORD INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs9422,365 39.8%   
Low Rs4501,625 27.7%   
Sales per share (Unadj.) Rs691.4430.3 160.7%  
Earnings per share (Unadj.) Rs11.578.7 14.6%  
Cash flow per share (Unadj.) Rs15.493.2 16.5%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.31.0 28.7%  
Book value per share (Unadj.) Rs380.0586.5 64.8%  
Shares outstanding (eoy) m3.9045.75 8.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.6 21.7%   
Avg P/E ratio x60.725.3 239.6%  
P/CF ratio (eoy) x45.321.4 211.7%  
Price / Book Value ratio x1.83.4 53.8%  
Dividend payout %17.425.4 68.7%   
Avg Mkt Cap Rs m2,71491,271 3.0%   
No. of employees `0000.42.6 16.9%   
Total wages/salary Rs m5053,143 16.1%   
Avg. sales/employee Rs Th6,073.07,484.8 81.1%   
Avg. wages/employee Rs Th1,137.41,195.0 95.2%   
Avg. net profit/employee Rs Th100.71,369.1 7.4%   
INCOME DATA
Net Sales Rs m2,69619,685 13.7%  
Other income Rs m1251,143 11.0%   
Total revenues Rs m2,82220,828 13.5%   
Gross profit Rs m-465,003 -0.9%  
Depreciation Rs m15663 2.3%   
Interest Rs m104 226.2%   
Profit before tax Rs m545,479 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101,878 0.5%   
Profit after tax Rs m453,601 1.2%  
Gross profit margin %-1.725.4 -6.8%  
Effective tax rate %17.734.3 51.6%   
Net profit margin %1.718.3 9.1%  
BALANCE SHEET DATA
Current assets Rs m1,73824,167 7.2%   
Current liabilities Rs m5459,544 5.7%   
Net working cap to sales %44.374.3 59.6%  
Current ratio x3.22.5 126.0%  
Inventory Days Days4855 88.0%  
Debtors Days Days429 15.0%  
Net fixed assets Rs m129,514 0.1%   
Share capital Rs m39458 8.5%   
"Free" reserves Rs m1,44326,375 5.5%   
Net worth Rs m1,48226,832 5.5%   
Long term debt Rs m025 0.0%   
Total assets Rs m2,07736,900 5.6%  
Interest coverage x6.71,305.5 0.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.5 243.4%   
Return on assets %2.69.8 26.7%  
Return on equity %3.013.4 22.5%  
Return on capital %4.320.4 21.1%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m1722 76.8%   
Fx outflow Rs m6731,489 45.2%   
Net fx Rs m-656-1,466 44.7%   
CASH FLOW
From Operations Rs m903,318 2.7%  
From Investments Rs m105-2,383 -4.4%  
From Financial Activity Rs m-14-1,104 1.3%  
Net Cashflow Rs m181-169 -107.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 63.9 117.4%  
Indian inst/Mut Fund % 3.8 7.5 50.7%  
FIIs % 0.1 4.9 2.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 23.7 89.5%  
Shareholders   4,783 85,207 5.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT LTD.  VENUS REMEDIES  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 118 Points Higher; Realty and Banking Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours of trade and ended the day marginally higher.

Related Views on News

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY19); Net Profit Up 60.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, PFIZER has posted a net profit of Rs 918 m (up 60.6% YoY). Sales on the other hand came in at Rs 5 bn (up 18.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS